Ontario Teachers Pension Plan Board Sells 4,023 Shares of Chemed Corporation $CHE

Ontario Teachers Pension Plan Board lessened its stake in Chemed Corporation (NYSE:CHE) by 67.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,969 shares of the company’s stock after selling 4,023 shares during the period. Ontario Teachers Pension Plan Board’s holdings in Chemed were worth $959,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. SVB Wealth LLC bought a new stake in shares of Chemed in the 1st quarter valued at about $30,000. WPG Advisers LLC bought a new position in shares of Chemed during the 1st quarter worth approximately $32,000. Creekmur Asset Management LLC bought a new position in shares of Chemed during the 2nd quarter worth approximately $28,000. Parkside Financial Bank & Trust lifted its position in Chemed by 86.3% during the second quarter. Parkside Financial Bank & Trust now owns 95 shares of the company’s stock valued at $46,000 after acquiring an additional 44 shares during the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after acquiring an additional 76 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Chemed news, CEO Kevin J. Mcnamara sold 3,000 shares of Chemed stock in a transaction that occurred on Friday, September 26th. The shares were sold at an average price of $461.28, for a total transaction of $1,383,840.00. Following the completion of the sale, the chief executive officer directly owned 96,197 shares in the company, valued at approximately $44,373,752.16. The trade was a 3.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Patrick P. Grace sold 150 shares of the company’s stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $463.39, for a total transaction of $69,508.50. Following the completion of the sale, the director directly owned 3,397 shares in the company, valued at $1,574,135.83. This trade represents a 4.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 3.29% of the company’s stock.

Chemed Price Performance

Shares of CHE stock opened at $435.18 on Monday. The firm has a market capitalization of $6.16 billion, a price-to-earnings ratio of 23.01, a price-to-earnings-growth ratio of 2.69 and a beta of 0.43. The business has a fifty day moving average of $443.97 and a 200 day moving average of $482.84. Chemed Corporation has a 1 year low of $408.42 and a 1 year high of $623.60.

Chemed (NYSE:CHE) last posted its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing the consensus estimate of $5.39 by ($0.12). The firm had revenue of $624.90 million for the quarter, compared to analysts’ expectations of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.64 EPS. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, equities research analysts expect that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 5th. Investors of record on Monday, November 17th will be issued a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, November 17th. Chemed’s dividend payout ratio is 12.69%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CHE. Oppenheimer reduced their price target on Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a research report on Thursday, July 31st. Royal Bank Of Canada reduced their target price on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and increased their price target for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, October 8th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Chemed has an average rating of “Moderate Buy” and an average price target of $574.25.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.